Cargando…
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia
BACKGROUND: Achondroplasia is a rare genetic disease is characterized by abnormal bone development and early obesity. While the bone aspect of the disease has been thoroughly studied, early obesity affecting approximately 50% of them during childhood has been somewhat neglected. It nevertheless repr...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898762/ https://www.ncbi.nlm.nih.gov/pubmed/29652901 http://dx.doi.org/10.1371/journal.pone.0195876 |